Qifeng Luo

1.6k citations
53 papers · 1.1k indexed · h-index 19
Topics
MicroRNA in disease regulation (13 papers)Circular RNAs in diseases (11 papers)Cancer-related molecular mechanisms research (8 papers)
Partner nations
ChinaFranceUnited States

In The Last Decade

Qifeng Luo

46 papers receiving 1.1k citations

Peers

Qifeng Luo
Comparison fields: 5 of 108
  • Molecular Biology 790
  • Cancer Research 581
  • Oncology 201
  • Epidemiology 102
  • Pulmonary and Respiratory Medicine 101
Replace Xinju Zhang with:
Xinju Zhang China
Na Che China
Yong Ni China
Yun Cui China
Shu‐Juan Xie China
Liwei Zhang China
Dongkai Zhou China
Jianlin Zhou China
Zengren Zhao China
Liwei Qiu China
Qifeng Luo relative to Xinju Zhang China Xinju Zhang's profile →
Citations per field
00.5×1.7×
Xinju Zhang · 1×
Citations per year

Countries citing papers authored by Qifeng Luo

Since Specialization
Citations

This map shows the geographic impact of Qifeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Luo more than expected).

Fields of papers citing papers by Qifeng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Luo. The network helps show where Qifeng Luo may publish in the future.

Co-authorship network of co-authors of Qifeng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng Luo. A scholar is included among the top collaborators of Qifeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng Luo. Qifeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 10
4 4
5 4
6 49
7 17
8 35
9 23
10 67
11 53
12 23
13 0
14 75
15 61
16
Location-aided ZRP in MANET
1
17
Theory of Monte-Carlo Method and Implementation in ANSYS
0
18
Effect of Fault Fracture Zone on the Ground Motion of Non-causative Fault Site
1
19 0
20 1

About Qifeng Luo

Qifeng Luo is a scholar working on Cancer Research, General Engineering and Geophysics, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (11 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (581 citations), Molecular Biology (790 citations) and Oncology (201 citations). Qifeng Luo has collaborated with scholars based in China, France and United States. Frequent co-authors include Lin Fang, Xiaoyu Li, Xiangjie Kong, Junfeng Zhang, Jia Li, Yixiang Huang, Chuankui Wei, Lei Chen, Hongming Song and Dengfeng Li. Their work appears in journals such as PLoS ONE, Nature Cell Biology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026